TC Biopharm (TCBP) News Today $0.68 -0.86 (-55.78%) Closing price 03/21/2025Extended Trading$0.68 0.00 (0.00%) As of 03/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period TC BioPharm: TCBP Announces Transition from Nasdaq to OTC MarketsMarch 24, 2025 | finanznachrichten.deTC BioPharm to be delisted from Nasdaq, moves to OTC MarketsMarch 23, 2025 | uk.investing.comTC Biopharm announces transition to OTC Markets from NasdaqMarch 22, 2025 | markets.businessinsider.comTC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses FrustrationMarch 21, 2025 | msn.comTC BioPharm Transitions from Nasdaq to OTC Markets Amid Delisting NoticeMarch 21, 2025 | tipranks.comTCBP Announces Transition from Nasdaq to OTC MarketsMarch 21, 2025 | prnewswire.comTC Biopharm launches cost reduction initiativesMarch 19, 2025 | finance.yahoo.comTCBP Announces Outsourcing Initiatives, Reducing Burn Rate and OverheadMarch 18, 2025 | prnewswire.comTC BioPharm: TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical CompanyMarch 5, 2025 | finanznachrichten.deTCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical CompanyMarch 5, 2025 | prnewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for WeekFebruary 28, 2025 | msn.comTCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO ForumFebruary 20, 2025 | prnewswire.comTC BioPharm: TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical TrialFebruary 13, 2025 | finanznachrichten.deTCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical TrialFebruary 13, 2025 | prnewswire.comTC BioPharm: TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical TrialFebruary 11, 2025 | finanznachrichten.deTC Falls Despite Cohort B TrialsFebruary 11, 2025 | baystreet.caTC Biopharm completes initial Cohort B patient dosing in ACHIEVE trialFebruary 10, 2025 | markets.businessinsider.comTCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical TrialFebruary 10, 2025 | prnewswire.comTC Biopharm (Holdings) PLC – ADR trading halted, news pendingFebruary 8, 2025 | markets.businessinsider.comTC BioPharm: TCBP to Implement ADS Ratio ChangeFebruary 6, 2025 | finanznachrichten.deTCBP to Implement ADS Ratio ChangeFebruary 5, 2025 | prnewswire.comTCBP Announces H5N1 Proof of Concept Studies IntentionJanuary 15, 2025 | prnewswire.comTCBP to Present at Sequire Investor Summit 2025January 13, 2025 | prnewswire.comTC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-ComplianceJanuary 8, 2025 | tipranks.comTC BioPharm: TCBP Trading Continues Unabated on Nasdaq Stock ExchangeJanuary 7, 2025 | finanznachrichten.deTCBP Trading Continues Unabated on Nasdaq Stock ExchangeJanuary 6, 2025 | prnewswire.comEuropean Equities Traded in US as American Depositary Receipts Surge on MondayJanuary 6, 2025 | msn.comTC BioPharm: TCBP Provides Update on Acquisition Strategy and Current TargetsJanuary 2, 2025 | finanznachrichten.deTCBP Provides Update on Acquisition Strategy and Current TargetsDecember 31, 2024 | prnewswire.comTC Biopharm shareholders approve 25% stock dividendDecember 31, 2024 | markets.businessinsider.comTC BioPharm Approves Key Resolutions to Enhance Strategic FlexibilityDecember 30, 2024 | tipranks.comTCBP Issues 25% Stock DividendDecember 30, 2024 | prnewswire.comTCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 PatientsDecember 20, 2024 | prnewswire.comTCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder DividendDecember 18, 2024 | prnewswire.comEXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock DividendDecember 18, 2024 | benzinga.comTCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyDecember 11, 2024 | prnewswire.comTCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical TrialDecember 4, 2024 | prnewswire.comTCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantNovember 12, 2024 | prnewswire.comTCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsOctober 30, 2024 | prnewswire.comTCBP Responds to False Social Media ClaimOctober 25, 2024 | prnewswire.comTC BioPharm (Holdings) plcOctober 24, 2024 | thestreet.comTC Biopharm enters research pact with Dr. Carlos Maluquer de MotesOctober 23, 2024 | markets.businessinsider.comBiotech Shares Rip Following Collaboration Announcement For Monkeypox ResearchOctober 22, 2024 | theglobeandmail.comTCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticOctober 22, 2024 | prnewswire.comTC Biopharm (Holdings) PLC – ADR trading resumesOctober 22, 2024 | markets.businessinsider.comTC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pauseOctober 22, 2024 | markets.businessinsider.comTC Biopharm (NASDAQ:TCBP) Shares Up 14.8% - Should You Buy?TC Biopharm (NASDAQ:TCBP) Stock Price Up 14.8% - Here's What HappenedOctober 5, 2024 | marketbeat.comTCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningOctober 3, 2024 | prnewswire.comTCBP Announces Site Opening of Guys and St. Thomas HospitalSeptember 25, 2024 | prnewswire.comBioMedNewsBreaks — TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Featured at Next Month’s NYC ThinkEquity ConferenceSeptember 24, 2024 | msn.com Remove Ads Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBP and its competitors with MarketBeat's FREE daily newsletter. Email Address TCBP Media Mentions By Week TCBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCBP News Sentiment▼0.330.78▲Average Medical News Sentiment TCBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCBP Articles This Week▼51▲TCBP Articles Average Week Remove Ads Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Trevena News Evofem Biosciences News Viracta Therapeutics News MyMD Pharmaceuticals News AEON Biopharma News Petros Pharmaceuticals News Avenue Therapeutics News Biora Therapeutics News TransCode Therapeutics News Aditxt News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCBP) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCBP Stock Free TCBP Stock Alerts